While encompassing the overall mission of M. D. Anderson Cancer Center, the particular goals of the Department of Thoracic/Head and Neck Medical Oncology are to provide the highest quality of care to our patients and to advance the treatment and prevention of aerodigestive cancers through innovative clinical and laboratory research.

Our investigations involve many of the most promising molecularly-targeted agents and combinations of agents currently known.  We emphasize rigorous study conduct and impeccable study design, and many of our studies have been developed through cooperative group mechanisms.  For more information see the Lung Cancer and the Head and Neck Cancer Clinical Trials on the M. D. Anderson Clinical Trials webpage.

We are currently recruiting current and former smokers for a lung cancer chemoprevention trial to study the effects of Celecoxib (Celebrex).  Read More.

The Department of Thoracic/Head and Neck Medical Oncology staff directly responsible for patient care is comprised of 17 physicians, 27 research nurses, three inpatient mid-level providers, and 15 outpatient mid-level providers. Our physician team includes eight physicians who care only for thoracic medical oncology patients in the Thoracic Center and nine medical oncologists who treat both lung cancer and head/neck cancer patients in those respective outpatient clinic areas.